Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free PILL Stock Alerts $6.77 +0.06 (+0.89%) (As of 05/7/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy2.65Holdings in PILL have an aggregate rating of Moderate Buy based on 296 analyst ratings issued in the past year covering 40 companies (84.9% of the portfolio).PILL Aggregate Price Target$11.0262.80% UpsideHigh Prediction$13.90Average Prediction$11.02Low Prediction$8.05Holdings in PILL have an aggregate price target of $11.02 and a range of $8.05 to $13.90 covering 40 companies (84.9% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 PILL Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.58%ITCIIntra-Cellular Therapies$71.21+0.3%5 of 5 stars2.90$90.17 26.6%10Analyst ForecastNews Coverage4.54%MRKMerck & Co., Inc.$130.38+2.2%5 of 5 stars2.58$131.33 0.7%124.36%PRGOPerrigo$30.15-9.8%5 of 5 stars3.00$40.67 34.9%3Earnings ReportDividend AnnouncementNews CoverageGap DownHigh Trading Volume4.28%OGNOrganon & Co.$20.40-1.4%5 of 5 stars2.50$22.60 10.8%4Dividend Announcement4.23%CTLTCatalent$56.53+0.3%3 of 5 stars2.15$52.46 -7.2%13Analyst Forecast4.15%AXSMAxsome Therapeutics$76.94+1.3%4 of 5 stars2.92$122.17 58.8%13Analyst ForecastNews Coverage4.08%LLYEli Lilly and Company$777.77+1.4%5 of 5 stars2.84$757.95 -2.5%19Earnings ReportDividend Announcement4.01%VTRSViatris$11.72-0.8%0 of 5 stars1.33$11.00 -6.1%3Upcoming Earnings3.98%PFEPfizer$27.78-1.4%5 of 5 stars2.38$36.00 29.6%16Earnings ReportAnalyst Revision3.97%RPRXRoyalty Pharma$28.28-0.7%5 of 5 stars3.00$46.75 65.3%4Upcoming Earnings3.94%JNJJohnson & Johnson$148.72+0.1%5 of 5 stars2.46$175.86 18.2%13Analyst Forecast3.92%JAZZJazz Pharmaceuticals$111.21+1.2%5 of 5 stars2.85$192.75 73.3%13Insider Selling3.61%ZTSZoetis$168.45+1.5%5 of 5 stars3.00$212.38 26.1%7Earnings ReportAnalyst ForecastAnalyst Revision3.56%BMYBristol-Myers Squibb$44.04+0.3%5 of 5 stars2.11$60.00 36.2%193.40%ELANElanco Animal Health$13.53+2.0%3 of 5 stars2.57$16.71 23.6%7Positive News2.92%CORTCorcept Therapeutics$24.48+2.1%5 of 5 stars3.00$40.10 63.8%4Earnings ReportInsider SellingAnalyst Revision2.16%ARVNArvinas$34.33+6.4%2 of 5 stars2.88$59.73 74.0%16Upcoming EarningsNews Coverage1.87%AMPHAmphastar Pharmaceuticals$42.77+0.2%5 of 5 stars2.50$66.00 54.3%4Upcoming Earnings1.83%SAVACassava Sciences$21.83+1.4%3 of 5 stars3.00$124.00 468.0%11.65%EYPTEyePoint Pharmaceuticals$11.87+6.0%3 of 5 stars3.00$33.50 182.2%6Analyst ForecastNews CoverageHigh Trading Volume1.49%TARSTarsus Pharmaceuticals$38.03+2.7%3 of 5 stars2.88$48.38 27.2%8Upcoming Earnings1.27%PBHPrestige Consumer Healthcare$69.95-0.1%4 of 5 stars2.50$110.00 57.3%2Upcoming EarningsAnalyst RevisionPositive News1.05%PCRXPacira BioSciences$26.51+0.0%5 of 5 stars3.00$49.50 86.7%10News Coverage1.04%LBPHLongboard Pharmaceuticals$22.05+7.0%3 of 5 stars3.00$43.67 98.1%6Analyst ForecastNews Coverage1.02%HRMYHarmony Biosciences$31.36+1.5%4 of 5 stars2.50$40.63 29.5%8Gap Up0.98%COLLCollegium Pharmaceutical$37.30+0.8%2 of 5 stars2.60$39.00 4.6%5Upcoming Earnings0.86%LQDALiquidia$12.84+1.2%2 of 5 stars2.60$21.00 63.6%5Upcoming EarningsPositive News0.80%AMLXAmylyx Pharmaceuticals$1.97-1.0%4 of 5 stars2.25$32.67 1,558.2%8Upcoming Earnings0.77%SUPNSupernus Pharmaceuticals$31.15+2.4%4 of 5 stars3.00$41.00 31.6%10.75%AMRXAmneal Pharmaceuticals$6.51-2.1%2 of 5 stars3.00$8.25 26.7%4Analyst Forecast0.70%LGNDLigand Pharmaceuticals$73.22+0.5%5 of 5 stars3.00$116.33 58.9%3Earnings ReportNews Coverage0.56%ANIPANI Pharmaceuticals$66.72-1.0%5 of 5 stars3.00$80.00 19.9%4Upcoming Earnings0.51%PLRXPliant Therapeutics$13.794 of 5 stars3.00$45.67 231.2%10Analyst ForecastNews Coverage0.48%RVNCRevance Therapeutics$4.38+6.8%4 of 5 stars2.50$13.75 213.9%8Upcoming Earnings0.40%EOLSEvolus$13.42+0.2%4 of 5 stars3.00$20.60 53.5%3News Coverage0.34%TBPHTheravance Biopharma$9.54-0.6%1 of 5 stars3.00$20.50 114.9%2Upcoming Earnings0.30%XERSXeris Biopharma$1.88-1.1%4 of 5 stars3.00$4.88 159.3%4Upcoming Earnings0.28%OCULOcular Therapeutix$5.93+2.2%4 of 5 stars3.00$17.60 196.8%5Upcoming Earnings0.24%FULCFulcrum Therapeutics$7.54-2.7%2 of 5 stars2.83$13.17 74.6%6Upcoming Earnings0.06%MRNSMarinus Pharmaceuticals$1.57+6.1%4 of 5 stars2.57$13.79 778.1%7Analyst Forecast This page (NYSEARCA:PILL) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
